AgNovos Bioscience

New York, United States

AgNovos is a regenerative technology that restores the structure and biomechanics of bone to transform the paradigm of care for osteoporosis

$31.5M raised

Jun 2023

Series B

Biotechnology Health Care Life Science Medical Medical Device

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AgNovos Bioscience

How much funding has AgNovos Bioscience raised?

AgNovos Bioscience has raised $31.5M in total funding. The most recent round was Series B. The last funding was announced in June 2023.

Where is AgNovos Bioscience headquartered?

AgNovos Bioscience is headquartered in New York, United States.

What does AgNovos Bioscience do?

AgNovos is a regenerative technology that restores the structure and biomechanics of bone to transform the paradigm of care for osteoporosis

What stage is AgNovos Bioscience at?

AgNovos Bioscience is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 9, 2023.

MLA

"AgNovos Bioscience — Funding & Investors." VCBacked, June 9, 2023, https://www.vcbacked.co/company/agnovos-bioscience. Accessed July 3, 2026.

APA

VCBacked. (2023). AgNovos Bioscience — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/agnovos-bioscience

Wikipedia (cite web)

{{cite web |title=AgNovos Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/agnovos-bioscience |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 9, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K